Back to All Events

Vaccines and Related Biological Products Advisory Committee

The US FDA has scheduled a Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting for Thursday, May 17, 2018, to discuss two topics related to biologic products. Under Topic I, the Committee will discuss approaches for demonstrating effectiveness of group B streptococcus (GBS) vaccines intended for use in pregnant women to protect the newborn infant.  Under Topic II, the committee will hear an overview of the research program in the Laboratory of Respiratory Viral Diseases (LRVD), Division of Viral Products, Office of Vaccines Research and Review, CBER, FDA.